Airain Ltd’s Imperva, Inc. IMPV Stock Holding History

Airain Ltd’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-6,924	Closed	-$438K	–	1189
2015 Q4	$438K	Buy	6,924 +3,234	+88%	+$220K	0.03%	494
2015 Q3	$242K	Sell	3,690 -7,538	-67%	-$500K	0.01%	647
2015 Q2	$760K	Buy	+11,228	New	+$620K	0.04%	413
2015 Q1	–	Sell	-5,322	Closed	-$263K	–	1031
2014 Q4	$263K	Buy	+5,322	New	+$213K	0.02%	526

Other funds holding IMPV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

Airain Ltd's IMPV Position: Q1 2016 in Review

Airain Ltd sold out of Imperva, Inc. (IMPV) in Q1 2016, closing a stake of 6,924 shares — an estimated $438K sold.

Airain Ltd first reported a position in IMPV in Q4 2014 and held it in 4 quarters. The position peaked at $760K in Q2 2015. 160 funds tracked by Wall St. Rank hold IMPV as of Q1 2016.

Airain Ltd reported no remaining Imperva, Inc. position as of Q1 2016 after selling out during the quarter.
Airain Ltd sold 6,924 Imperva, Inc. shares in Q1 2016, an estimated $438K.
Airain Ltd first reported a position in Imperva, Inc. in Q4 2014 and held it in 4 quarters.
Airain Ltd's Imperva, Inc. position peaked at $760K in Q2 2015.
160 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2016.

Based on Airain Ltd's 13F filing for Q1 2016, filed 9 May 2016.